Innovative Emerging Molecular Analysis Technologies (SBIR R43/R44)

The summary for the Innovative Emerging Molecular Analysis Technologies (SBIR R43/R44) Federal Grant is detailed below. It contains information such as the Catalog of Federal Domestic Assistance (CFDA) number, who is eligible for the grant, how much grant money will be awarded, important deadlines, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed in the Grant Announcement Contact section. If these sections are incomplete, please visit the website of the government agency that is offering this grant.


	Federal Grant Title:	Innovative Emerging Molecular Analysis Technologies (SBIR R43/R44)
	CFDA Number:	93.393
	CFDA Description:	Cancer Cause and Prevention Research
	Federal Agency Name:	National Institutes of Health
	Category of Funding Activity:	Education Health
	Category Explanation:	Information not provided
	Opportunity Category:	Discretionary
	Funding Opportunity Number:	RFA-CA-10-013
	Document Type:	Grants Notice
	Funding Instrument Type:	Grant
	Posted Date:	Sep 14, 2010
	Creation Date:	Sep 14, 2010
	Original Closing Date for Applications:	Feb 08, 2011
	Current Closing Date for Applications:	Feb 08, 2011
	Archive Date:	Mar 11, 2011
	Expected Number of Awards:	Information not provided
	Estimated Total Program Funding:	$2,000,000
	Federal Grant Award Ceiling:	Information not provided
	Federal Grant Award Floor:	Information not provided
	Cost Sharing or Matching Requirement:	No

Applicants Eligible for this Grant: Small businesses
Additional Information on Eligibility: Information not provided
Grant Description: Purpose. This Funding Opportunity Announcement (FOA) solicits grant applications from small business concerns (SBCs) proposing research towards commercial development of emerging molecular and/or cellular analytical technologies intended for cancer detection and/or characterization. The goal of this FOA is to facilitate the translation of innovative, cancer-relevant technologies into commercial products and/or services. The emphasis is on molecular analysis technologies to improve cancer prevention, detection and diagnosis, surveillance, epidemiological research, and basic cancer research. These technologies may be intended for molecular and cellular analyses in vitro, in situ, and/or in vivo. There must be sound rationale pointing to the commercial potential of the technology to be developed. Mechanism of Support. This FOA will utilize the SBIR R43/R44 grant mechanisms for Phase I, Phase II, and Fast-Track applications. Funds Available and Anticipated Number of Awards. The estimated amount of funds available for support of five to seven projects awarded under this announcement is $2 million for fiscal year 2011. Future year amounts will depend on annual appropriations.
Link to Full Grant Announcement: http://grants.nih.gov/grants/guide/rfa-files/rfa-ca-10-013.html
Grant Announcement Contact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [FBOWebmaster@OD.NIH.GOV]
Similar Government Grants: • Alliance of Glycobiologists for Detection of Cancer (U01); • Cancer Target Discovery and Development (CTDD) Network (U01); • Community Clinical Oncology Program Research Bases (U10); • Minority-Based Community Clinical Oncology Program Groups (U10); • Community Clinical Oncology Program Groups (U10); • Pilot Studies in Pancreatic Cancer; • CANCER PREVENTION RESEARCH SMALL GRANT PROGRAM; • MOLECULAR TARGETS FOR NUTRIENTS IN PROSTATE CANCER PREVENTION; • Cancer Prevention Research Small Grant Program (R03); • Pilot Studies in Pancreatic Cancer (R03)